Pyrazolo[3,4-d]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S262000

Reexamination Certificate

active

07964607

ABSTRACT:
The invention provides PDE9-inhibiting compounds of Formula (I),and pharmaceutically acceptable salts thereof, wherein R, R1, R2and R3are as defined herein. Pharmaceutical compositions containing the compounds of Formula I, and uses thereof in treating neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia, are also provided.

REFERENCES:
patent: 2003/0139427 (2003-07-01), Castelhano et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 2004/0259870 (2004-12-01), Feng et al.
patent: 1460077 (2004-09-01), None
patent: 02085904 (2002-10-01), None
patent: 2004037176 (2004-05-01), None
Wunder et al., Mol. Pharmacol., vol. 28, No. 6, (2005), pp. 1776-1781.
van der Staay et al., Neuropharmacology, vol. 55 (2008), pp. 908-918.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo[3,4-d]pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo[3,4-d]pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-d]pyrimidine compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2675757

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.